Clinical Trial Update: Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia

View source ↗

Summary

AstraZeneca-sponsored centralized Pan-Russian survey on undertreatment of hypercholesterolemia (dyslipidemia) has completed, summarizing management gaps in chol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidaemia | Status: COMPLETED